Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Challenging Cancer in 2016: A Year in Review

Tackling cancer complexities in 2016 at the Academy.

Published December 19, 2016

Challenging Cancer in 2016: A Year in Review

It is estimated that more than a million new cases of cancer are diagnosed in the United States each year, but research presented in 2016 at the Academy provided innovative insights and progress in the fight to eradicate cancer across the lifespan. From exposing genetic vulnerabilities to highlighting promising treatments, the Academy brought together leading experts for events on a range of cancer-related topics to further our understanding and propel towards improved treatments—and ultimately, a cure.


Understanding the Biological Basis of Pediatric Cancer

Advances in genomic medicine indicate that pediatric cancers may be quite different from their adult counterparts. Hear from experts on why this might be and what scientists are doing to understand it better.


Disease Drivers of Aging: The 2016 Advances in Geroscience Summit

This eBriefing looks at how chronic diseases—specifically HIV/AIDS, diabetes, and cancer—affect aging, with a focus on the seven mechanistic pillars of aging.


Emerging Approaches to Cancer Immunotherapy

Cancer immunotherapy, which engages the immune system to detect and destroy cancer cells, has gained popularity and success in recent years. This eBriefing features investigational approaches to better engineer or train the immune system to improve its responses, combat treatment resistance, and avoid adverse effects.

News Item

Persistence Pays Off for Neuroblastoma Researcher, Fifteen Years Later

Learn how John Maris, MD, got to the heart of the (genetic) matter in his research.


Epigenetics: Cancer and Beyond

Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.


Phenotypic and Biomarker-based Drug Discovery

This eBriefing considers the merits of phenotypic drug discovery, which is experiencing a renaissance of interest. The method aims to find therapeutically useful compounds by screening thousands of substances for functional cellular outputs.


Sohn Conference: Pediatric Cancer in a Post-genomic World

This eBriefing covers the latest research on pediatric cancers, including topics such as etiological differences between pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.

News Item

New Cancer Therapies Aim Above & Beyond the Genome

Cancer researcher Christopher Vakoc, PhD, goes “above the genome” in search for leukemia drug targets.